HLI•November 20, 2026 at 3:41 PM UTCFinancial Services

Private Credit Stress Fails to Shift HLI's Cautious Setup

Read source article

What happened

Houlihan Lokey has released analysis from its proprietary Private Credit DataBank showing widening cracks in private credit, including third-quarter 2026 loan defaults, deteriorating borrower earnings, leverage, interest coverage, and valuations across direct lending. The development underscores an increasingly stressed credit environment, which could eventually drive more restructuring mandates for HLI. However, the company's latest filings already indicated corporate expenses rising 30% year-over-year and margin pressure from acquisition integration while mid-market M&A volumes lag larger deals. The new private credit data does not address these headwinds and provides no hard numbers on how much restructuring revenue could rise. Consequently, the news is a modest positive for the countercyclical restructuring franchise but does not alter the fundamental risk/reward for the stock at current valuation.

Implication

Investors should monitor upcoming quarterly results for evidence that private credit stress is translating into higher Financial Restructuring segment revenue and a meaningful offset to any mid-market M&A softness. Without clear signpost on magnitude, the article's implied benefit remains speculative and insufficient to justify paying ~24x trailing earnings for a success-fee-driven business. The rise in corporate expenses and acquisition-related costs continues to threaten pre-tax margin resilience, which would be exacerbated if deal closings in the core corporate finance segment falter. A pullback toward the ~$145 attractive entry or multiple quarters of sustained >12% revenue growth with margins holding ≥25% would provide a better risk-adjusted opportunity. Until such evidence emerges, the asymmetry remains unfavorable for new longs, supporting a hold or trim rather than adding at current levels.

Thesis delta

The new private credit stress data introduces a potential near-term positive for HLI's restructuring segment but does not resolve the existing concerns around mid-market M&A weakness, rising fixed costs, and premium valuation. The core thesis—that at ~$164 the stock embeds smooth growth and stable margins in a volatile, success-fee-driven model—remains intact. We maintain our potential sell stance with an attractive entry near $145, while raising the importance of monitoring restructuring revenue conversion from credit distress.

Confidence

Medium